Eikon Therapeutics, Inc. SEC EDGAR Filings (CIK 0001861123)

SEC EDGAR filings, ownership reports, and insider transactions for Eikon Therapeutics, Inc..

Symbol
EIKN
Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
230 Harriet Tubman Way, Millbrae, CA, 94030
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Eikon Therapeutics, Inc. has filed 38 SEC EDGAR filings since 13 May 2021

Latest Filings

Recent SEC filings for Eikon Therapeutics, Inc. including SCHEDULE 13D, SCHEDULE 13G, 4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 12 Feb 2026 005-95483
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 11 Feb 2026 005-95483
4 Open 4 document View SEC filing for 4 4 10 Feb 2026 06 Feb 2026
4 Open 4 document View SEC filing for 4 4 09 Feb 2026 06 Feb 2026
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 06 Feb 2026 04 Feb 2026
4 Open 4 document View SEC filing for 4 4 06 Feb 2026 04 Feb 2026
4 Open 4 document View SEC filing for 4 4 06 Feb 2026 04 Feb 2026
4 Open 4 document View SEC filing for 4 4 06 Feb 2026 04 Feb 2026
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 06 Feb 2026 333-293272
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Feb 2026 06 Feb 2026 001-43085
424B4 Open 424B4 document View SEC filing for 424B4 424B4 05 Feb 2026 333-292633
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 3 04 Feb 2026 04 Feb 2026
S-1MEF Open S-1MEF document | Open XBRL data View SEC filing for S-1MEF S-1MEF 04 Feb 2026 333-293213
CERT Open CERT document View SEC filing for CERT 04 Feb 2026 001-43085
EFFECT Open EFFECT document View SEC filing for EFFECT 30 Jan 2026 333-292633
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 28 Jan 2026 001-43085
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1/A 28 Jan 2026 333-292633
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 09 Jan 2026 333-292633
DRS/A Open DRS/A document View SEC filing for DRS/A 12 Dec 2025 377-07990
DRS/A Open DRS/A document View SEC filing for DRS/A 26 Sep 2025 377-07990
DRS/A Open DRS/A document View SEC filing for DRS/A 01 Jul 2025 377-07990
DRS Open DRS document View SEC filing for DRS 09 May 2025 377-07990
D Open D document View SEC filing for D 28 Feb 2025 021-539574
D Open D document View SEC filing for D 01 Jun 2023 021-483121
D Open D document View SEC filing for D 06 Jan 2022 021-428246
D Open D document View SEC filing for D 13 May 2021 021-399311

About this filer

Eikon Therapeutics, Inc. files with the SEC under CIK 0001861123. This page aggregates EDGAR filings and related ownership activity.

Industry: Biological Products, (No Disgnostic Substances).

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages